What are the Historical Developments and Current Growth Metrics of the Hydrophilic Angiographic Catheters Market?
The hydrophilic angiographic catheters market has seen considerable growth due to a variety of factors.
• In recent times, the hydrophilic angiographic catheters market has seen robust growth. There is an expected leap from $12.6 $ billion in 2024 to $13.54 $ billion in 2025, indicative of a compound annual growth rate (CAGR) of 7.5%.
Factors contributing to the growth during the historic period include an uptick in cardiovascular diseases, increased cases of peripheral vascular diseases, a rise in diagnostic and interventional treatments, an escalation in early diagnosis and awareness, and a surge in healthcare spending.
What Is The Projected Growth Of The Hydrophilic Angiographic Catheters Template Market?
The hydrophilic angiographic catheters market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations for the hydrophilic angiographic catheters market predict substantial growth in the coming years. The market is predicted to increase to $17.88 billion in 2029 with a compound annual growth rate (CAGR) of 7.2%.
Factors contributing to growth during this period include an elderly population on the rise, preference for less invasive procedures, a high occurrence of diabetes, and enhanced funding towards cardiovascular research. Significant trends for the forecast period entail technological progress, penetration into new markets, advancements in imaging technology, escalating use within oncology, and a concentration on minimally invasive procedures.
What Are The Key Drivers Fueling Growth In The Hydrophilic Angiographic Catheters Market?
An upswing in renal disorders is anticipated to fuel the expansion of the hydrophilic angiographic catheters market. Renal disorders, which pertains to a wide range of conditions that hinder the kidneys' functionality to filter blood, eliminate waste, balance fluids and electrolytes and control blood pressure, are seeing a significant rise. This is primarily due to an escalated occurrence of risk factors including diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters come into play in renal disorders, providing precise and smooth navigation during diagnostic and interventional procedures like renal artery angiography and stenting. For example, as per a report published by Kidney Research UK, a non-profit organization in the UK, in June 2023, around 7.2 million inhabitants of the UK are afflicted with chronic kidney disease. This accounts for over 10% of the population, with 3.25 million people in advanced stages of the disease and another 3.9 million in the preliminary stages. It is expected that by 2033, the count of chronic kidney disease sufferers will have surged to 7.61 million. Due to this, the prevalence of renal disorders is acting as a growth driver for the hydrophilic angiographic catheters market.
What Are The Principal Market Segments In The Global Hydrophilic Angiographic Catheters Industry?
The hydrophilic angiographic cathetersmarket covered in this report is segmented –
1) By Type: Selective Type Angiographic Catheters, Non-Selective Type Angiographic Catheters
2) By Application: Heart Disease Treatment, Kidney Disease Treatment, Other Applications
3) By End User: Hospitals, Diagnostic And Imaging Centers, Other End-Users
Subsegments:
1) By Selective Type Angiographic Catheters: Coronary Selective Catheters, Peripheral Selective Catheters, Neuro Selective Catheters
2) By Non-Selective Type Angiographic Catheters: Non-Selective Coronary Catheters, Non-Selective Peripheral Catheters, Non-Selective Neuro Catheters
Pre-Book The Hydrophilic Angiographic Catheters Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Hydrophilic Angiographic Catheters Market?
The development of innovative products such as catheters featuring a variety of curve configurations is a key focus for major businesses in the hydrophilic angiographic catheters market as they seek to retain their market status. These catheters are innovative medical tools that are created with distinctive curves or bends that can negotiate complicated anatomical structures. For example, Cook Group Incorporated, a medical device firm based in the US, launched its Slip-Cath Beacon Tip hydrophilic selective catheter in the USA and Canada in January 2024. With more than 30 different curve configurations, this catheter is designed to be used in both vascular and non-vascular angiographic procedures. Packaged in protective foil to ensure prolonged durability and a three-year shelf life, it has advanced technology that improves usability during procedures and is designed to integrate seamlessly with vascular access sheaths, wire guides, and various therapeutic devices.
Who Are the Key Players In The Hydrophilic Angiographic Catheters Market?
Major companies operating in the hydrophilic angiographic catheters market are:
• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N.V.
• Becton Dickinson and Company
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Terumo Corporation
• Nipro Corporation
• Cook Medical Inc.
• Teleflex Incorporated
• BIOTRONIK SE & Co. KG
• Lepu Medical Technology (Beijing) Co Ltd.
• Merit Medical Systems Inc.
• Cordis Corporation
• MicroPort Scientific Corporation
• Asahi Intecc Co Ltd.
• AngioDynamics Inc.
• Biosensors International Group Ltd.
• Alvimedica Medical Technologies
• BrosMed Medical Co Ltd.
• iVascular SLU
• Reva Medical Inc.
• Hexacath
• Translumina Therapeutics LLP
• Eurocor Tech GmbH
• Invamed Group
What Are The Regional Insights Into The Hydrophilic Angiographic Catheters Market?
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2024. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
